Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)
Top Cited Papers
- 1 April 2012
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 33 (4), 322-327
- https://doi.org/10.1086/665010
Abstract
Antimicrobial resistance has emerged as a significant healthcare quality and patient safety issue in the twenty-first century that, combined with a rapidly dwindling antimicrobial armamentarium, has resulted in a critical threat to the public health of the United States. Antimicrobial stewardship programs optimize antimicrobial use to achieve the best clinical outcomes while minimizing adverse events and limiting selective pressures that drive the emergence of resistance and may also reduce excessive costs attributable to suboptimal antimicrobial use. Therefore, antimicrobial stewardship must be a fiduciary responsibility for all healthcare institutions across the continuum of care. This position statement of the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and the Pediatric Infectious Diseases Society of America outlines recommendations for the mandatory implementation of antimicrobial stewardship throughout health care, suggests process and outcome measures to monitor these interventions, and addresses deficiencies in education and research in this field as well as the lack of accurate data on antimicrobial use in the United States.Keywords
This publication has 34 references indexed in Scilit:
- An Unmet Medical Need: Rapid Molecular Diagnostics Tests for Respiratory Tract InfectionsClinical Infectious Diseases, 2011
- Combating Antimicrobial Resistance: Policy Recommendations to Save LivesClinical Infectious Diseases, 2011
- Emergence and Spread of Drug Resistant Neisseria gonorrhoeaeJournal of Urology, 2010
- Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccinesCurrent Opinion in Pulmonary Medicine, 2010
- Multidrug-resistantPseudomonas aeruginosaandAcinetobacter baumannii: resistance mechanisms and implications for therapyExpert Review of Anti-infective Therapy, 2010
- Antimicrobial resistance in typhoidal and nontyphoidal salmonellaeCurrent Opinion in Infectious Diseases, 2008
- Imipenem Resistance Among Pseudomonas aeruginosa Isolates Risk Factors for Infection and Impact of Resistance on Clinical and Economic OutcomesInfection Control & Hospital Epidemiology, 2006
- Comparison of Community- and Health Care–Associated Methicillin-Resistant Staphylococcus aureus InfectionJAMA, 2003
- Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in HospitalsClinical Infectious Diseases, 1997
- Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in HospitalsInfection Control & Hospital Epidemiology, 1997